As of Feb 16
| -0.09 / -0.26%|
The 32 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 38.04, with a high estimate of 50.17 and a low estimate of 24.92. The median estimate represents a +12.11% increase from the last price of 33.93.
The current consensus among 36 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.